Healthcare stocks have become a haven for investors ditching tech

Healthcare stocks, particularly those of AbbVie, Eli Lilly, and Johnson & Johnson, are surging to record highs, indicating a renewed investor interest in the biopharmaceutical sector. This shift away from tech stocks reflects a broader trend where investors are seeking stability and growth potential in healthcare, which is seen as a more resilient sector amid market volatility. The resurgence in healthcare stocks underscores the sector's long-term growth prospects, driven by an aging population and advancements in medical technology. This movement could signal a strategic realignment in investor portfolios, prioritizing sectors perceived as more secure.